GeneralConnection.com ➔ Dictionary
Dictionary Search

agonist

Synonyms

Noun

1. protagonist

2. fictional character, fictitious character, character, contestant

3. antagonistic muscle

4. drug

Usage
Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection - Nature
AstraZeneca (AZN) Advances Oral GLP-1 Receptor Agonist Elecoglipron to Phase III Trials - Insider Monkey
Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial - Nature
Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial - Nature
A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases - Nature
Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications - investor.lilly.com
Retatrutide, the newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery - UCHealth
AstraZeneca (AZN) Advances Oral GLP-1 Receptor Agonist Elecoglipron to Phase III Trials - Yahoo Finance Singapore
Continuation of GLP-1 Receptor Agonist Use in Early Pregnancy Seems Safe - Optometry Advisor
GLP-1 Receptor Agonists for Obesity Management in Older Adults: A Scoping Review on the Risk of Sarcopenia and Sarcopenic Obesity - Springer Nature Link
Is there anything GLP-1 agonist drugs cannot do? - DW.com
GLP-1 medications may reduce violent behavior in adults - News-Medical
GLP-1 Receptor Agonists Improve Cirrhosis Outcomes Over Metabolic-Bariatric Surgery - Docwire News
Beta cell–targeted PD-1 agonist inhibits cell-mediated autoimmunity in pancreas tissue slices - Science | AAAS
Study Disputes Link Between GLP-1 Drugs and Higher Optic Neuropathy Risk - Review of Optometry
[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Yahoo Finance Singapore
GLP-1 Receptor Agonists Market Gains Momentum as Weight-Loss Drugs Redefine Diabetes and Heart Care - Says Strategic Market Research - Yahoo Finance Singapore
Genetic predictors of GLP1 receptor agonist weight loss and side effects - Nature
An oral, liver-restricted LXR inverse agonist for dyslipidemia: preclinical development and phase 1 trial - Nature
Facile induction of immune tolerance by an interleukin-2–TGFβ surrogate agonist - Nature
Structural and dynamic insights into agonist recognition and function of the thromboxane A2 receptor - Nature
GLP-1s Tied to Lower Healthcare Use in Migraine Patients - Medscape
A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trial - Nature
Development of a clinically viable MRGPRX4 inverse agonist for cholestatic itch treatment - Nature
Discovery of a small molecule TLR3 agonist adjuvant - Nature
WHO’s new guidance on maintaining opioid agonist maintenance treatment as an essential health service - World Health Organization (WHO)
Psychedelic 5-HT2A agonist increases spontaneous and evoked 5-Hz oscillations in visual and retrosplenial cortex - Nature
Can use of popular weight loss medications reduce behaviors linked to violent crime? - Medical Xpress
ENDO: GLP-1 receptor agonists tied to higher hypotension risk in patients on BP meds - Medical Xpress
Glucagon-like peptide-1 receptor agonist in large vessel occlusion treated by reperfusion therapy—a phase 2 randomized trial - Nature
Semaglutide Linked to Fewer Fractures - Medscape
GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits - The Lancet
Tumour-specific STING agonist synthesis via a two-component prodrug system - Nature
Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes - investor.lilly.com
Activation of GPR97/ADGRG3 by its tethered agonist, but not by beclomethasone, induces neutrophil polarization and migration - Science | AAAS
GTP release-selective agonists prolong opioid analgesic efficacy - Nature
Noncanonical agonist-dependent and -independent arrestin recruitment of GPR1 - Science | AAAS
Tirzepatide outperformed semaglutide weight-loss drug results in real world patients, study shows - Medical Xpress
Structural basis for diosgenin as an inverse agonist of retinoic acid receptor-related orphan receptor γ - Nature
GLP-1 obesity drugs linked to fewer asthma attacks and reduced inhaler use - Labmate-Online
Breast Imaging in Focus: Can GLP-1 Receptor Agonists Reduce Breast Cancer Risk? What New Research Reveals - diagnosticimaging.com
Soluble Notch agonist enables human ameloblast maturation and enamel-like tissue formation for tooth regeneration - Nature
Pearls & Oy-sters: Use of Short-Acting B-Agonist in DOK7-Related Congenital Myasthenic Syndrome Treatment - Neurology® Journals
Additional benefits of combining GLP-1 receptor agonist use with lifestyle modification - The Lancet
Agonist signaling drives neutrophil subpopulations to promote/inhibit colorectal cancer liver metastasis - Nature
Association Between GLP-1 Receptor Agonist Use and Epilepsy Risk in Type 2 Diabetes - Neurology® Journals
Post-resection delivery of a TLR7/8 agonist from a biodegradable scaffold achieves immune-mediated glioblastoma clearance and protection against tumor challenge in mice - Nature
New GLP-1 diabetes pill delivers major weight loss and blood sugar control - ScienceDaily
Preclinical efficacy of the muscarinic agonist ML-007 in psychosis models depends on both M - Nature
LNP-based delivery of a Toll-like receptor 9 agonist elicits potent adjuvant effects and antitumor immunity - Nature
GLP-1 Use May Benefit Autoimmune Disease Patients With Obesity - TCTMD.com
New Weight Loss Drugs: How Many Americans Have Used Them? - RAND
GLP-1 agonist drugs show digestive side effects but may help fight infections - Medical Xpress
Could a once-a-day pill replace weight loss injections? Phase II oral GLP-1 drug trial shows promising results - Medical Xpress
GLP-1 Receptor Agonists and Reduced Breast Cancer Risk: Is There More to the Story? - diagnosticimaging.com
Spotlight On: Key takeaways from ADA - FirstWord PHARMA
Reprogramming tumor microenvironment via systemic delivery of TLR3 agonist and manganese nanoparticle - PNAS
Crystal structures of agonist-bound human cannabinoid receptor CB1 - Nature
GLP-1 agonist-associated presentations to unscheduled care: An opportunistic pilot study - British Pharmacological Society | Journals
Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139 - Nature
GLP-1 Therapies Silence Spontaneous Physical Activity - Neuroscience News
Alkermes Granted Orphan Drug Designations for Alixorexton in US, Europe - Sleep Review
Study finds exercise decreases among people taking GLP-1 medication - Medical Xpress
Cryo-EM structures of ρ1 GABAA receptors with antagonist and agonist drugs - Nature
Targeting pregnane X receptor with a potent agonist-based PROTAC to delay colon cancer relapse | Oncogenesis - Nature
GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders - Journal of Neuroscience
Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity - Nature
ADA conference roundup: GLP-1 trial results and researchers removed by police - drugdiscoverytrends.com
GLP-1s may aid bone health as well as weight loss in type 2 diabetes - Medical News Today
Zinc pyrithione functions as a small-molecule STING agonist to exert antitumor immunotherapy effects - Nature
Peptide vaccine formulations with structurally distinct STING agonist drugamers induce discrete, efficacious antitumor responses - PNAS
First GLP-1 tablet for weight loss approved in the UK - GOV.UK
Weight Loss Drugs Like Ozempic May Lower Breast Cancer Risk and Slow Disease Progression - Discover Magazine
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccine - Nature
Rhythm Pharmaceuticals Announces Multiple New Data Presentations From Mc4r Agonists - TradingView
Orforglipron, an Oral GLP-1 Receptor Agonist, in Early Type 2 Diabetes - The New England Journal of Medicine
Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease - investor.lilly.com
What do GLP-1 receptor agonists actually do? - VCU Health
Could a once-a-day pill replace weight loss injections? Phase II oral GLP-1 drug trial shows promising results - Medical Xpress
New Study Finds GLP-1 Medications May Reduce Risk of Violent Behavior - Bioengineer.org
How Lilly is defending its GLP empire - Pharma Voice
Heterochiral Design Yields Potent Class B1 GPCR Agonists - Bioengineer.org
GLP-1 Drugs May Carry Rare Risk of Vision Loss, Experts Call for Vigilance: Research - Medical Dialogues
Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026 - Carroll County Mirror-Democrat
Rhythm trial finds up to 38% BMI drop in complex rare obesity cases - Stock Titan
Examining the impact of GLP-1 receptor agonist use on quality of bowel preparation for colonoscopy - Mayo Clinic
Alkermes (ALKS) wins orphan drug designations in U.S. and Europe for alixorexton - Stock Titan
Does Ozempic Reduce the Risk of Breast Cancer by 30%? - english.factcrescendo.com
Structure-guided design of partial agonists at an opioid receptor - Nature
Agonist activation to open the Gα subunit of the GPCR–G protein precoupled complex defines functional agonist activation of TAS2R5 - PNAS
Rhythm Pharmaceuticals (RYTM) reports strong MC4R obesity data across PWS, HO and BBS at ENDO 2026 - Stock Titan
Class B1 GPCR activation by an intracellular agonist - Nature
Immune inhibitory receptor agonist therapeutics - Frontiers
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone - Nature
Cryo-EM structure of small-molecule agonist bound delta opioid receptor-G - Nature
Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1 - The New England Journal of Medicine
Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia - The New England Journal of Medicine
STING agonist-based ER-targeting molecules boost antigen cross-presentation - Nature
A bitopic agonist bound to the dopamine 3 receptor reveals a selectivity site - Nature
Mechanistic insights into G-protein coupling with an agonist-bound G-protein-coupled receptor - Nature
Foreign Language Equivalents
Foreign Language Equivalents of 'agonist'
Language Equivalent   Language Equivalent
French angoissant    Spanish
Misspellings - Typos
agonsit,   agonits,   gaonist,   agonis,   agoonist,   agonisst,   agonisr,   agobist,   sgonist,   agnist,   agoniist,   agonistt,   afonist,   agpnist,   agonit,   agonisy,   agonnist,   agnoist,   gonist,   aginist,   agonst,   agoniat,   aonist,   ahonist,   agoinst,   aognist,   aagonist,   agonost,   agomist,   agonidt,   agoist,   aggonist,   agonust
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z